Consistently, our data also displayed that EBF1 overexpression reversed inhibitory effects of sh-LINC00663 on inflammation and vascular mimicry in BC cells, and further animal experiments showed that silencing LINC00663 decreased NR2F1 expression by binding EBF1, thereby repressing BC inflammation and angiogenesis. This evidence concerns the gene EBF1 and breast cancer.